CC

Checkpoint Capital

North America, Texas, United States, Austin

Description

Checkpoint Capital provides banking, asset-liability management, bond portfolio accounting, outsourced CIO and risk management services.

Investor Profile

Checkpoint Capital has made 3 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (33%)
  • Series C (33%)
  • Post Ipo Equity (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Biopharma
  • Medical
  • Alternative Medicine
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Checkpoint Capital frequently co-invest with?

BP
North America, California, United States, San Francisco
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
VC
North America, Wyoming, United States, Jackson
Co-Investments: 1
Braidwell
North America, Connecticut, United States, Stamford
Co-Investments: 1
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Frazier Life Sciences
North America, California, United States, Menlo Park
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Viking Global Investors
North America, Connecticut, United States, Stamford
Co-Investments: 1
Lightspeed Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by Checkpoint Capital?

Cidara Therapeutics

San Diego, California, United States

Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityNov 21, 2024
Amount Raised: $105,000,000
Elektrofi

Boston, Massachusetts, United States

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Alternative MedicineBiotechnologyTherapeutics
Series CAug 22, 2024
Amount Raised: $112,250,000
Diagonal Therapeutics

Cambridge, Massachusetts, United States

Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies.

BiopharmaBiotechnologyMedical
Series AApr 3, 2024
Amount Raised: $128,000,000